New Retina Radio by Eyetube
Ein Podcast von Eyetube
191 Folgen
-
New Retina Radio Journal Club w/ VBS: Risk Factors for Switching from Bevacizumab to Aflibercept in Protocol AC
Vom: 19.7.2024 -
From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME
Vom: 11.7.2024 -
New Retina Radio Journal Club w/ VBS: RVOs During the COVID Pandemic
Vom: 27.6.2024 -
A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World
Vom: 20.6.2024 -
AMD and DME Applications in the Retina Practice: Real-world Data
Vom: 17.6.2024 -
ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/Depression
Vom: 5.6.2024 -
New Retina Radio Journal Club with VBS: New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR?
Vom: 29.5.2024 -
ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE
Vom: 17.5.2024 -
GA Options in Clinical Therapy, Part 2: Real-world Cases in GA
Vom: 10.5.2024 -
GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies
Vom: 10.5.2024 -
AMD and DME Applications in the Retina Practice: RCT Comparison
Vom: 8.5.2024 -
The State of Biosimilars: Integration of Biosimilars into a Retina Practice
Vom: 25.4.2024 -
New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT
Vom: 19.4.2024 -
Successful Management of Vitreous Opacities
Vom: 2.4.2024 -
New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery
Vom: 28.3.2024 -
The State of Biosimilars: How We Got Here and What It Means for Practice
Vom: 22.2.2024 -
Cherchez la Femme Revisited
Vom: 16.2.2024 -
AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic
Vom: 14.12.2023 -
New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMD
Vom: 7.12.2023 -
AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments
Vom: 30.11.2023
New Retina Radio is a place to hear stories about retina that are told nowhere else.
